Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

Delayed Quote. Delayed  - 08/25 04:59:30 pm
311.6 DKK   -0.89%
08/22 NOVO NORDISK A/ : Helicopter View of A Sustainable City
08/22 NOVO NORDISK A/ : - Share repurchase programme
08/15 NOVO NORDISK A/ : - Share repurchase programme
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
09:51p NOVO NORDISK A/S : Patent Issued for Combination Therapy to Enhance NK Cell Medi..
07:47p NOVO NORDISK A/S : Goulston & Storrs Advises Hana Asset Management-Led Consortiu..
07:26p NOVO NORDISK A/S : HFF Closes $305 Million Sale of Novo Nordisk's Headquarters i..
08/22 NOVO NORDISK A/S : Helicopter View of A Sustainable City
08/22 NOVO NORDISK A/S : - Share repurchase programme
08/15 NOVO NORDISK A/S : - Share repurchase programme
08/12 NOVO NORDISK A/S : ex-dividend day for interim dividend
08/11 NOVO NORDISK A/S : Report Summarizes Type 2 Diabetes Study Findings from Novo No..
08/09 NOVO NORDISK A/S : NHS Scotland approves Novo Nordisk's diabetes drug
08/08 NOVO NORDISK A/S : increased adjusted operating profit by 8% in local currencies..
08/05 CAVERION : Delivers a Large Project for Novo Nordisks New Insulin Production Fac..
08/05 NOVO NORDISK A/S : #WeAreNotWaiting
08/05 NOVO NORDISK A/S : beats 2Q profit forecasts
08/05 CAVERION : delivers a Large Project for Novo Nordisk's new insulin production fa..
08/05DJNOVO NORDISK A/S : 2Q Net Profit Surges 19%
08/05 NOVO NORDISK A/S : increased adjusted operating profit by 8% in local currencies..
08/04 NOVO NORDISK A/S : New Findings from Novo Nordisk in the Area of Type 2 Diabetes..
08/04 NOVO NORDISK A/S : Reports from Novo Nordisk Advance Knowledge in Blood Coagulat..
08/04 NOVO NORDISK A/S : Certain Recombinant Factor VIII Products; Determination To Re..
08/04 NOVO NORDISK A/S : - Share repurchase programme
08/03 NOVO NORDISK A/S : Diabetes drug shunned by Express Scripts Business briefing
08/02NOVO NORDISK A/S : half-yearly earnings release
08/02DJNOVO NORDISK A/S : 2Q 2016 -- Forecast
08/01 NOVO NORDISK A/S : - Share repurchase programme
07/28 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Aleutian ..
07/28 STUDIES FROM NOVO NORDISK YIELD NEW : Effects of BMI, Hypertension,...
07/28 NOVO NORDISK A/S : James Shehan, Former General Counsel at Novo Nordisk, Joins L..
07/28 NOVO NORDISK A/S : Findings from Novo Nordisk in the Area of Ethanol Reported (H..
07/28 DIAMYD MEDICAL : Companion Medical receives FDA clearance
07/25 NOVO NORDISK A/S : - Share repurchase programme
07/23 NOVO NORDISK A/S : 66% of diabetes sufferers unaware
07/21 NOVO NORDISK A/S : Researchers at Novo Nordisk Report New Data on Stem Cell Rese..
07/21 NOVO NORDISK A/S : The Digital Health Connection in Africa
07/18 NOVO NORDISK A/S : - Share repurchase programme
07/14 NOVO NORDISK A/S : Unique New Book Series from Novo Nordisk and JDRF Uses Custom..
07/12 NOVO NORDISK A/S : to present 28 abstracts at the World Federation of Hemophilia..
07/11 NOVO NORDISK A/S : - Share repurchase programme
07/07 NOVO NORDISK A/S : Inc. Partners with Tony Award®-Winning Actor and Entertainer ..
07/07 NOVO NORDISK A/S : Findings on Hormones Reported by Investigators at Novo Nordis..
07/07 NOVO NORDISK A/S : Reports from Novo Nordisk Provide New Insights into Hypoglyce..
07/07 NOVO NORDISK A/S : Partnerships Are the New Black
07/05 NOVO NORDISK A/S : invests $ 59 mn to expand insulin plant in Denmark
07/04 NOVO NORDISK A/S : invests DKK 400 million in an expanded production plant in Ka..
07/01 NOVO NORDISK A/S : and Aarhus University team up for protein technology R&D
07/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (30..
07/01 NOVO NORDISK A/S : - Share repurchase programme
06/29 NOVO NORDISK A/S : Scores One for Partnerships
06/29 Novo Nordisk eyes technology tie-ups
06/29 Novo Nordisk eyes technology tie-ups
06/28 NOVO NORDISK A/S : EMA grants marketing authorisation of mylife(TM) YpsoPump® fo..
06/27 NOVO NORDISK A/S : - Share repurchase programme
06/26 NOVO NORDISK A/S : Danish healthcare organization seeks to expand collaboration ..
06/25 NOVO NORDISK A/S : Danish health team seeks cooperation beyond merely treating d..
06/23 NOVO NORDISK A/S : Patent Issued for Regeneration of Chromatographic Stationary ..
06/20 NOVO NORDISK A/S : - Share repurchase programme
06/16 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Type 2 Di..
06/16 NOVO NORDISK A/S : Study Findings on Mycoplasma Are Outlined in Reports from Nov..
06/16 NOVO NORDISK DETAILS FINDINGS IN TYP : Clinical Pharmacokinetics and Pharmacodyn..
06/16 BRENNTAG : Specialties Inc. (BSI) Expands Pharmaceutical, Over-the-Counter (OTC)..
06/14 NOVO NORDISK A/S : Team Novo Nordisk Seeks Young Athletes with Type 1 Diabetes
06/14 FASTING WITH DIABETES : Novo Nordisk Aims To Help Patients During Ramadan
06/14 NOVO NORDISK A/S : Victoza® significantly reduced the risk of major cardiovascul..
06/14 NOVO NORDISK A/S : Can a bunch of doctors keep an $8 billion secret? Not on Twit..
06/14 NOVO NORDISK A/S : Study Finds Victoza® Significantly Reduced the Risk of Heart ..
06/13 NOVO NORDISK A/S : presents new findings for Tresiba and semaglutide
06/13 NOVO NORDISK A/S : Faster-acting insulin aspart showed a statistically significa..
06/13 NOVO NORDISK A/S : Sewer pact aids Novo expansion
06/13 NOVO NORDISK A/S : Faster-acting insulin aspart showed a statistically significa..
06/13 NOVO NORDISK A/S : - Share repurchase programme
06/13 NOVO NORDISK A/S : Tresiba® (insulin degludec injection U-100) demonstrated sign..
06/13 NOVO NORDISK A/S : Semaglutide demonstrated superior improvements in glycaemic c..
06/09 NOVO NORDISK A/S : Reports Outline DNA Research Findings from Novo Nordisk
06/09 NOVO NORDISK A/S : Researchers at Novo Nordisk Report New Data on Immunoglobulin..
06/08 DIABETES : the scourge of city living
06/06 NOVO NORDISK A/S : - Share repurchase programme
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( DKK)
Sales 2016 113 807 M
EBIT 2016 49 524 M
Net income 2016 38 583 M
Finance 2016 14 222 M
Yield 2016 2,28%
P/E ratio 2016 20,62
P/E ratio 2017 18,74
EV / Sales 2016 5,43x
EV / Sales 2017 5,08x
Capitalization 632 750 M
More Financials
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 31
Average target price 378  DKK
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Rebien Sørensen President & Chief Executive Officer
Göran Albert Ando Chairman
Jesper Brandgaard Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Alan C. Moses Global Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-21.38%95 801
JOHNSON & JOHNSON15.57%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.45%213 882
PFIZER INC.7.87%211 206
MERCK & CO., INC.18.76%173 462
More Results